0001894562-24-000012.txt : 20240223 0001894562-24-000012.hdr.sgml : 20240223 20240223170242 ACCESSION NUMBER: 0001894562-24-000012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240221 FILED AS OF DATE: 20240223 DATE AS OF CHANGE: 20240223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEE ANN L. CENTRAL INDEX KEY: 0001723629 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41536 FILM NUMBER: 24672381 MAIL ADDRESS: STREET 1: 400 DEXTER AVENUE NORTH STREET 2: SUITE 1200 CITY: SEATTLE STATE: WA ZIP: 98109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prime Medicine, Inc. CENTRAL INDEX KEY: 0001894562 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-465-0013 MAIL ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wk-form4_1708725737.xml FORM 4 X0508 4 2024-02-21 0 0001894562 Prime Medicine, Inc. PRME 0001723629 LEE ANN L. C/O PRIME MEDICINE, INC. 21 ERIE STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Technical Officer 0 Stock Option (right to buy) 8.49 2024-02-21 4 A 0 180995 0 A 2034-02-21 Common Stock 180995 180995 D 1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 21, 2024, subject to the Reporting Person's continued service on each such vesting date. /s/ Karen Brown, attorney-in-fact 2024-02-23